Golden Meditech : APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities of the Company.

GOLDEN MEDITECH HOLDINGS LIMITED

金 衛 醫 療 集 團 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 00801) APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER

Reference is made to the joint announcement dated 13 January 2017 (the "Joint Announcement") issued by Golden Meditech Holdings Limited (the "Company") and Magnum Opus 3 International Holdings Limited (the "Offeror") in relation to the Offers that would be made by China Minsheng Banking Corp., Ltd., for and on behalf of the Offeror, to acquire all of the issued Shares (other than those already owned or agreed to be acquired by the Offeror and its Concert Parties), all outstanding Convertible Notes and to cancel all outstanding Share Options of the Company. Unless otherwise defined, capitalised terms used herein shall have the same meanings as those defined in the Joint Announcement.

The Board is pleased to announce that Akron Corporate Finance Limited, a corporation licensed to carry out Type 6 (advising on corporate finance) regulated activities under the SFO, has been appointed as the Independent Financial Adviser to advise the Independent Board Committee in respect of the Offers. Such appointment has been approved by the Independent Board Committee pursuant to Rule 2.1 of the Code. The letter of advice of the Independent Financial Adviser in respect of the Offers will be included in the Composite Document.

Hong Kong, 17 January 2017

By order of the board of

Golden Meditech Holdings Limited KONG Kam Yu

Executive Director

As at the date of this announcement, the Board comprises 8 Directors. The executive Directors are Mr. KAM Yuen (Chairman) and Mr. KONG Kam Yu; the non-executive Directors are Ms. ZHENG Ting and Mr. GAO Yue; and the independent non-executive Directors are Prof. CAO Gang, Mr. FENG Wen, Prof. GU Qiao and Mr. Daniel FOA. The Directors jointly and severally accept full responsibility for the accuracy of the information contained in this announcement and confirm, having made all reasonable inquiries, that to the best of their knowledge, opinions expressed in this announcement have been arrived at after due and careful consideration and there are no other facts not contained in this announcement the omission of which would make any statement in this announcement misleading.